OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced the following companies are verified for trading on the OTCQB® Venture Marketplace:
BioCorRx Inc. (OTCQB: BICX) – BioCorRx is a healthcare company on the leading edge of addiction treatment. The company has developed a treatment program called the Start Fresh Program that is used by various licensed addiction clinics throughout the United States. The program consists of two components: BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and other substances for several months and as long as a year in some patients, depending on individual metabolism rates. BioCorRx also owns a life coaching program that is tailored specifically to alcoholics and some other addictions. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results. BioCorRx's revolutionary treatment program has a very high success rate as reported by patients to the clinics that use the program in routine interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.
Cardax, Inc. (OTCQB: CDXI) – Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing consumer health and pharmaceutical products that it believes will provide many of the anti-inflammatory benefits of steroids or NSAIDS by targeting many of the same inflammatory pathways and mediators, but with exceptional safety profiles. Cardax is preparing proprietary nature-identical products and related derivatives by total synthesis to provide scalable, pure, and economical therapies for diseases where inflammation and oxidative stress are strongly implicated, including, but not limited to, osteoarthritis, rheumatoid arthritis, dyslipidemia, metabolic disease, diabetes, cardiovascular disease, hepatitis, cognitive decline, macular degeneration, and prostate disease. The initial primary focus of Cardax is its astaxanthin technologies. Astaxanthin is a powerful and safe naturally occurring anti-inflammatory and anti-oxidant without the adverse side effects typical of anti-inflammatory treatments using steroids or NSAIDS, including immune system suppression, liver damage, cardiovascular disease risk, and gastrointestinal bleeding. The safety and efficacy of Cardax's product candidates have not been directly evaluated in clinical trials or confirmed by the FDA.
Dais Analytic Corp. (OTCQB: DLYT) – Dais Analytic is engaged in the commercialization of its current and newer advancing nano-materials for applications spanning multiple industries in several distinct markets. Employing operational knowledge of its nano-materials it is executing a business model of creating, testing, and commercializing value-added-products in energy, homeland security, immersion coatings, and clean water.
First Bankers Trustshares, Inc. (OTCQB: FBTT) – First Bankers Trustshares is a bank holding company for First Bankers Trust Company, N.A., First Bankers Trust Services, Inc., FBIL Statutory Trust II and FBIL Statutory Trust III. The company was incorporated on August 25, 1988 and is headquartered in Quincy, Illinois.
Its mission, through its subsidiaries, is to provide comprehensive financial products and services to its retail, institutional and corporate customers.
First Bankers Trust Company, N.A. (the Bank) is a community-oriented financial institution which traces its beginnings to 1946, operates in 10 banking facilities in 5 counties in central and western Illinois.
First Bankers Trust Services, Inc. (the Trust Company) is a national provider of fiduciary services to individual retirement accounts, personal trusts, and employee benefit plans. It is headquartered in Quincy Illinois and operates offices in Hinsdale, IL, St. Peters, MO, Phoenix, AZ, Philadelphia, PA and Springfield, IL.
FBIL II and FBIL III were capitalized in 2003 and 2004, respectively, for the purpose of issuing Company Obligated Mandatorily Redeemable Preferred Securities.
Integrity Applications Incorporation (OTCQB: IGAP) – Integrity Applications is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for diabetes patients. The GlucoTrack(R) model DF-F is CE Mark Approved since June 2013. The company focuses now in preparation for mass production and distribution agreements.
Meridian Waste Solutions, Inc. (OTCQB: MRDN) – Meridian Waste Solutions provided non-hazardous solid waste collection and recycling services for approximately 40,000 commercial, industrial and residential customers in the St. Louis, Missouri marketplace.
Vapir Enterprises Inc. (OTCQB: VAPI) – We invent, develop and manufacture revolutionary, state-of-the-art and user friendly medical-grade vaporization devices.
Our vaporizers extract active ingredients from source by a unique and a proprietary process, and deliver very high quality, natural vapor for the best user experience.
WindStream Technologies, Inc. (OTCQB: WSTI) – Windstream Technologies is engaged in the development and commercialization of wind driven electrical generation products in the United States and internationally. The company offers small-wind and hybrid renewable energy devices that are suitable for on or off grid installations under the TurboMill and SolarMill names. It also provides various accessory products in support of these devices, including mounting equipment, data collection/monitoring equipment, batteries, inverters, and various wiring solutions and accessories. The company was founded in 2008 and is headquartered in North Vernon, Indiana.
Wisconsin Electric Power Co. (OTCQB: WELPM, WELPP) – Wisconsin Electric Power Company, a subsidiary of Wisconsin Energy Corporation, was incorporated in the state of Wisconsin in 1896. It maintains its principal executive offices in Milwaukee, Wisconsin.
It conducts its operations primarily in three reportable segments: an electric utility segment, a natural gas utility segment and a steam utility segment. As of December 31, 2014, it serves approximately 1,133,600 electric customers in Wisconsin and the Upper Peninsula of Michigan, approximately 475,100 gas customers in Wisconsin and approximately 440 steam customers in metropolitan Milwaukee, Wisconsin. For further financial information about its business segments, see Results of Operations in Item 7 and Note O -- Segment Reporting in the Notes to Consolidated Financial Statements in Item 8 in Wisconsin Electric's 2014 Annual Report on Form 10-K.
Wisconsin Energy is also the parent company of Wisconsin Gas LLC (Wisconsin Gas), a natural gas distribution utility, which serves customers throughout Wisconsin; and W.E. Power, LLC (We Power), a non-utility company that was formed in 2001 to design, construct, own and lease to us the generating capacity included in Wisconsin Energy's Power the Future (PTF) strategy. It has combined common functions with Wisconsin Gas and operate under the trade name of "We Energies."
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for these companies on www.otcmarkets.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected
financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to inform investors of opportunities and risks: the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and the OTC Pink® Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
Media Contact:
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com